ArticlePharmacoEconomics2012

A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand.

Rajan Ragupathy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.